Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: A prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

2005

British Journal of Haematology , Volume 128 - Issue 1 p. 59- 65

Additional Metadata
Keywords	Acute myeloid leukaemia, Autologous stem cell transplantation, Consolidation therapy, First complete remission, Phase III trial
Persistent URL	doi.org/10.1111/j.1365-2141.2004.05282.x, hdl.handle.net/1765/66004
Journal	British Journal of Haematology
Organisation	Department of Hematology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Breems, D., Boogaerts, M., Dekker, A., van Putten, W., Sonneveld, P., Huijgens, P., van der Lelie, J., Vellenga, E., Gratwohl, A., Verhoef, G., Verdonck, L.& Löwenberg, B. (2005). Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: A prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial. British Journal of Haematology, 128(1), 59–65.https://doi.org/10.1111/j.1365-2141.2004.05282.x

Publication